Fund Holdings — Remedium Capital Partners, LLC

Total Portfolio Value:
$273.59M
Total Bought:
$273.59M
Total Sold:
$0
Net Transaction:
+$273.59M
Securities
▲▼
SharesValue
Q2 2026
▲▼
Q3 2026
▲▼
Change
▲▼
Q2 2026
▲▼
Q3 2026
▲▼
Weight (%)
▲▼
Change
▲▼
Spyre Therapeutics, Inc.(SYRE)01,160,620+1,160,620$0$103.33M37.77%+$103.33M
Oruka Therapeutics, Inc.(ORKA)0954,150+954,150$0$79.47M29.05%+$79.47M
Damora Therapeutics, Inc.(DMRA)02,045,473+2,045,473$0$43.53M15.91%+$43.53M
Jade Biosciences Inc01,807,814+1,807,814$0$25.40M9.28%+$25.40M
Korsana Biosciences Inc0518,500+518,500$0$16.59M6.06%+$16.59M
Crescent Biopharma Inc0361,250+361,250$0$5.27M1.93%+$5.27M
Page 1 of 1
Remedium Capital Partners, LLC — 13F Holdings — Q3 2026 | TickerTrail